BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32747405)

  • 1. Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function.
    Taylor GS; Smith K; Capper TE; Scragg JH; Bashir A; Flatt A; Stevenson EJ; McDonald TJ; Oram RA; Shaw JA; West DJ
    Diabetes Care; 2020 Oct; 43(10):2362-2370. PubMed ID: 32747405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetes.
    Taylor GS; Shaw AC; Smith K; Wason J; McDonald TJ; Oram RA; Stevenson E; Shaw JAM; West DJ
    Diabet Med; 2022 May; 39(5):e14814. PubMed ID: 35181926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.
    Sherr J; Tamborlane WV; Xing D; Tsalikian E; Mauras N; Buckingham B; White NH; Arbelaez AM; Beck RW; Kollman C; Ruedy K;
    Diabetes Care; 2012 Apr; 35(4):817-20. PubMed ID: 22323414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic β-Cell Function Is Associated with Augmented Counterregulation to In-Exercise Hypoglycemia in Type 1 Diabetes.
    McCarthy O; Pitt J; Eckstein ML; Moser O; Bain SC; Bracken RM
    Med Sci Sports Exerc; 2021 Jul; 53(7):1326-1333. PubMed ID: 34127632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.
    Fuhri Snethlage CM; McDonald TJ; Oram RD; de Groen P; Rampanelli E; Schimmel AWM; Holleman F; Siegelaar S; Hoekstra J; Brouwer CB; Knop FK; Verchere CB; van Raalte DH; Roep BO; Nieuwdorp M; Hanssen NMJ
    Diabetes Care; 2024 Jul; 47(7):1114-1121. PubMed ID: 37535870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring.
    Juel CTB; Dejgaard TF; Hansen CP; Storkholm JH; Vilsbøll T; Lund A; Knop FK
    J Clin Endocrinol Metab; 2021 Jan; 106(1):168-173. PubMed ID: 33053154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High residual C-peptide likely contributes to glycemic control in type 1 diabetes.
    Rickels MR; Evans-Molina C; Bahnson HT; Ylescupidez A; Nadeau KJ; Hao W; Clements MA; Sherr JL; Pratley RE; Hannon TS; Shah VN; Miller KM; Greenbaum CJ;
    J Clin Invest; 2020 Apr; 130(4):1850-1862. PubMed ID: 31895699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting May Alter Blood Glucose Responses to High-Intensity Interval Exercise in Adults With Type 1 Diabetes: A Randomized, Acute Crossover Study.
    Yardley JE
    Can J Diabetes; 2020 Dec; 44(8):727-733. PubMed ID: 33160882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of Peak C-Peptide at Diagnosis Informs Glycemic Control but not Hypoglycemia in Adults With Type 1 Diabetes.
    Carr ALJ; Oram RA; Marren SM; McDonald TJ; Narendran P; Andrews RC
    J Endocr Soc; 2021 Oct; 5(10):bvab127. PubMed ID: 34377883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
    Brooks AM; Oram R; Home P; Steen N; Shaw JA
    Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Glucose Monitoring in Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycemia: Also Effective in Patients with Psychological Distress?
    van Beers CAJ; de Wit M; Kleijer SJ; Geelhoed-Duijvestijn PH; DeVries JH; Kramer MHH; Diamant M; Serné EH; Snoek FJ
    Diabetes Technol Ther; 2017 Oct; 19(10):595-599. PubMed ID: 28836833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes.
    Campbell MD; Walker M; Trenell MI; Jakovljevic DG; Stevenson EJ; Bracken RM; Bain SC; West DJ
    Diabetes Care; 2013 Aug; 36(8):2217-24. PubMed ID: 23514728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control during consecutive days with prolonged walking exercise in individuals with type 1 diabetes mellitus.
    van Dijk JW; Eijsvogels TM; Nyakayiru J; Schreuder TH; Hopman MT; Thijssen DH; van Loon LJ
    Diabetes Res Clin Pract; 2016 Jul; 117():74-81. PubMed ID: 27329025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.
    Shah VN; DuBose SN; Li Z; Beck RW; Peters AL; Weinstock RS; Kruger D; Tansey M; Sparling D; Woerner S; Vendrame F; Bergenstal R; Tamborlane WV; Watson SE; Sherr J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4356-4364. PubMed ID: 31127824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.
    Taylor GS; Smith K; Scragg J; McDonald TJ; Shaw JA; West DJ; Roberts LD
    Diabetologia; 2024 Jul; 67(7):1413-1428. PubMed ID: 38662134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives.
    Pickup JC; Ford Holloway M; Samsi K
    Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
    Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution.
    Fabris C; Ozaslan B; Breton MD
    Sensors (Basel); 2019 Dec; 19(24):. PubMed ID: 31817678
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Exercise Intensity on Exogenous Glucose Requirements to Maintain Stable Glycemia At High Insulin Levels in Type 1 Diabetes.
    Shetty VB; Fournier PA; Paramalingam N; Soon W; Roby HC; Jones TW; Davis EA
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e83-e93. PubMed ID: 33097945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.